隐匿性高血压发病机制、靶器官损伤及管理的研究进展  

Progress on Pathogenesis,Target Organ Damage and Management of Masked Hypertension

作　　者：陈辉[1] 吴艳君[1] CHEN Hui;WU Yanjun(Department of Cardiology,the Fourth Affiliated Hospital of Jiangsu University,Zhenjiang 212001,China)

机构地区：[1]江苏大学附属四院心内科,江苏省镇江市212001

出　　处：《实用心脑肺血管病杂志》2018年第12期1-5,共5页Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

摘　　要：隐匿性高血压(MH)是一种特殊类型高血压,主要表现为诊室测量血压正常,而家庭自测或动态监测血压升高。MH广泛存在于普通人群中,但由于其发病隐匿,多无明显临床症状,因此常被患者及医生忽视。研究表明,MH患者心血管疾病发生风险较血压正常者或血压控制良好者高1.5～3.0倍,其危险性与持续性高血压相似。因此,提高MH诊断率并采取有效干预措施对改善MH患者预后具有重要意义。本文主要综述了MH的发病机制、靶器官损伤及管理的研究进展,旨在提高临床医生对MH的认识。Masked hypertension(MH)is one kind of specific types of hypertension,mainly performed as normal blood pressure in the clinic and elevated blood pressure by family self-test or dynamic monitoring.MH is existed widely in ordinary crowd,but it is easily to be neglected due to the hidden onset and unconspicuous clinical symptoms in the most patients.Researches showed that,risk of cardiovascular disease rises by 1.5 to 3.0 times in MH patients than that in normotensive and hypertension patients with good control effect of blood pressure,which is similar to persistent hypertension.Improvement of diagnostic rate of MH and adopt effective interventions is of great significance to prove the prognosis.This paper mainly reviewed the progress on pathogenesis,target organ damage and management of MH,in order to improve the clinical understanding of MH.

关 键 词：隐匿性高血压 发病机制 靶器官损伤 疾病管理 综述 

分 类 号：R544[医药卫生—心血管疾病]